The technical trend for Indraprastha Medical Corporation has transitioned from bullish to mildly bullish, indicating a subtle adjustment in momentum. Weekly and monthly Moving Average Convergence Divergence (MACD) indicators maintain a bullish stance, suggesting underlying positive momentum over these periods. However, the Relative Strength Index (RSI) on both weekly and monthly charts shows no definitive signal, reflecting a neutral momentum phase without clear overbought or oversold conditions.
Bollinger Bands on weekly and monthly timeframes indicate a mildly bullish posture, implying moderate price volatility with a slight upward bias. Daily moving averages also align with a mildly bullish trend, supporting the notion of cautious optimism in the short term. Contrastingly, the Know Sure Thing (KST) indicator presents a bullish signal on the weekly chart but a mildly bearish indication on the monthly chart, highlighting a divergence in momentum perspectives across timeframes.
Only 1% make it here. This Large Cap from the Gems, Jewellery And Watches sector passed our rigorous filters with flying colors. Be among the first few to spot this gem!
- Highest rated stock selection
- Multi-parameter screening cleared
- Large Cap quality pick
Additional technical indicators provide a mixed outlook. The Dow Theory signals a mildly bearish trend on the weekly chart but a bullish trend on the monthly chart, suggesting short-term caution amid longer-term confidence. On-Balance Volume (OBV) shows no clear trend on either weekly or monthly scales, indicating volume patterns have not decisively influenced price direction recently.
From a price perspective, the stock’s 52-week high is ₹640.05, while the 52-week low is ₹307.90, positioning the current price closer to the upper range but reflecting some retracement from recent highs. Today’s trading range has been between ₹518.05 and ₹546.60, underscoring intraday volatility.
When comparing returns, Indraprastha Medical Corporation’s stock has shown varied performance relative to the Sensex benchmark. Over the past week, the stock recorded a return of -5.58% against the Sensex’s 0.96%. The one-month return for the stock is -6.37%, while the Sensex posted 0.86%. Year-to-date, the stock’s return is -0.44%, contrasting with the Sensex’s 8.36%. However, over longer horizons, the stock has outperformed significantly, with a one-year return of 26.65% versus the Sensex’s 9.48%, a three-year return of 485.93% compared to 37.31%, a five-year return of 941.20% against 91.65%, and a ten-year return of 688.19% relative to 232.28% for the Sensex.
Thinking about Indraprastha Medical Corporation ? Our real-time Verdict report breaks down everything – from financial health and peer comparison to technical signals and fair valuation for this small-cap stock!
- Real-time Verdict available
- Financial health breakdown
- Fair valuation calculated
Indraprastha Medical Corporation’s market capitalisation grade is 3, reflecting its standing within the hospital sector. The recent adjustment in its Mojo Score to 70.0, with a corresponding change in its Mojo Grade from Strong Buy to Buy as of 18 Nov 2025, indicates a revision in evaluation based on technical parameters. This adjustment aligns with the observed shift in technical trend from bullish to mildly bullish, signalling a recalibration of momentum assessment.
Investors analysing Indraprastha Medical Corporation should consider the interplay of these technical indicators alongside broader market conditions. The mixed signals from MACD, RSI, Bollinger Bands, and moving averages suggest a phase of consolidation or cautious positioning. The divergence between weekly and monthly indicators such as KST and Dow Theory further emphasises the importance of timeframe in interpreting momentum.
Overall, the technical landscape for Indraprastha Medical Corporation reflects a nuanced momentum shift rather than a decisive directional change. Market participants may find value in monitoring these indicators closely for confirmation of emerging trends or potential reversals, particularly given the stock’s historical outperformance relative to the Sensex over extended periods.
Get 2 full years of MojoOne Premium for only Rs. 12,999. Subscribe for 1 year and we'll add another year FREE. Offer valid for a limited time. Start Saving Now →
